JotPsych Secures $5M to Develop AI-Driven EHR

July 30, 2025
JotPsych has raised $5 million in seed funding from Base10 Partners to advance its AI scribe into a fully agentic Electronic Health Record (EHR) system.

JotPsych has raised $5 million in seed funding from Base10 Partners, as announced in a press release. The funding will accelerate the development of JotPsych's AI scribe into the first fully agentic Electronic Health Record (EHR) system.

JotPsych's AI scribe, initially designed to reduce documentation time for behavioral health providers by over 90%, will now expand to automate various administrative tasks. These include scheduling, billing, e-prescriptions, and care coordination, all under a unified platform.

The investment will enable JotPsych to hire additional engineering talent and enhance its research and development efforts. Upcoming features will integrate intake forms, automated coding and billing, prescription management, and intelligent scheduling, leveraging real-time patient data to ease clinicians' workload and improve patient outcomes.

Base10 Partners, known for investing in technology companies that address real-world problems, sees JotPsych as a leader in the emerging field of agentic EHR solutions. The venture capital firm believes that JotPsych is well-positioned to pioneer a new era in healthcare technology.

We hope you enjoyed this article.

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more